VEGFA and wet macular degeneration: Administration of intravitreal injections of anti-VEGF drugs, such as ranibizumab (Lucentis), bevacizumab (Avastin), and aflibercept (Eylea), to wet AMD patients is successfully and routinely being used as a wet AMD therapy worldwide [4,5].